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Abstract: Homeostatic scaling of synaptic strength in response to environmental stimuli may underlie
the beneficial effects of an active lifestyle on brain function. Our previous results highlighted a
key role for brain-derived neurotrophic factor (BDNF) and mitogen- and stress-activated protein
kinase 1 (MSK1) in experience-related homeostatic synaptic plasticity. Astroglia have recently
been shown to serve as an important source of BDNF. To elucidate a role for astroglia-derived
BDNF, we explored homeostatic synaptic plasticity in transgenic mice with an impairment in the
BDNF/MSK1 pathway (MSK1 kinase dead knock-in (KD) mice) and impairment of glial exocytosis
(dnSNARE mice). We observed that prolonged tonic activation of astrocytes caused BDNF-dependent
upregulation of excitatory synaptic currents accompanied by enlargement of synaptic boutons.
We found that exposure to environmental enrichment (EE) and caloric restriction (CR) strongly
upregulated excitatory but downregulated inhibitory synaptic currents in old wild-type mice,
thus counterbalancing the impact of ageing on synaptic transmission. In parallel, EE and CR enhanced
astrocytic Ca2+-signalling. Importantly, we observed a significant deficit in the effects of EE and
CR on synaptic transmission in the MSK1 KD and dnSNARE mice. Combined, our results strongly
support the importance of astrocytic exocytosis of BDNF for the beneficial effects of EE and CR on
synaptic transmission and plasticity in the ageing brain.
Keywords: aging; dendritic spines; synaptic strength; glia–neuron interactions; ion conductance
microscopy; synaptic scaling; diet; enriched environment; GABA receptors; AMPA receptors; TrkB
receptors; Arc/Arg3.1; calcium signalling
1. Introduction
The ability of neurons to autonomously scale their synaptic strength in response to hyper- or
hypoexcitability of their neighbours is instrumental for brain adaptation to environmental challenges
during development, adulthood, and ageing [1–3]. Such forms of adaptive changes in synaptic strength
are generally termed homeostatic synaptic plasticity [2]. The responsiveness of synapses and neuronal
networks to environmental stimuli has been linked to the potential beneficial effects of an active
lifestyle on the ageing brain [4–8].
Brain-derived neurotrophic factor (BDNF) has emerged as an important mediator of synaptic
adaptation to both activity deprivation and environmental enrichment [1,9,10]. Increased production
of BDNF has been observed in rodents in response to environmental enrichment [1,3], which, via the
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BDNF tropomyosin receptor kinase B (TrkB receptor), promotes dendritic growth, and increased spine
density [11].
The role of BDNF in synaptic adaptation relies on a number of proteins, including the cytoskeletal-
associated protein Arc/Arg3.1 and mitogen- and stress-activated protein kinase 1 (MSK1). In particular,
our previous data have shown a quintessential role for MSK1 in BDNF-mediated homeostatic
synaptic scaling in vitro, and the effects of environmental enrichment (EE) on synaptic transmission
in hippocampus in vivo [9]. Since the release of BDNF can be increased by various environmental
stimuli, such as physical activity or a change in diet [9,12,13], the BDNF/MSK1 pathway might play an
important role in the beneficial effects of both physical activity and caloric restriction (CR) on synaptic
function, in particular in the ageing brain.
Recent data has highlighted an important role for astroglia as a source of BDNF [14,15]. It has
been recently demonstrated that astrocytes can release BDNF via Ca2+-dependent exocytosis [14].
In addition, astrocytes, which mediate neurovascular coupling and orchestrate metabolic support of
neurons [16–18], are strategically positioned to mediate the effects of enhanced physical activity and
CR. Our recent results show that EE and CR can both enhance astroglial Ca2+-signalling [19]. Thus,
we hypothesise that astroglia-derived BDNF could be instrumental for homeostatic synaptic scaling
and experience-dependent synaptic plasticity.
To verify this hypothesis, we explored the effects of tonic activation of astrocytes in situ and
in vivo (via environmental stimuli) on synaptic scaling in transgenic mice with an impairment of
BDNF/MSK1 signalling (MSK1 kinase dead knock-in mice) and an impairment of glial exocytosis
(dnSNARE mice).
2. Materials and Methods
All animal work was carried out in accordance with UK legislation and “3R” strategy; research
did not involve non-human primates. This project was approved by the University of Warwick
Animal Welfare and Ethical Review Body (AWERB), approval number G13-19, and regulated under
the auspices of the UK Home Office Animals (Scientific Procedures) Act licenses P1D8E11D6 and
I3EBF4DB9. Experiments were performed in astrocytes and neurons of the hippocampus and
somatosensory cortex of dn-SNARE transgenic mice [19–22], their wild-type littermates (WT),
and transgenic mice with MSK1 kinase dead knock-in (MSK1 KD mice) [9]; the MSK1 KD mice
had the same genetic background as dnSNARE mice (C57/Bl6). We used mice of two age groups,
6–12 (average 7.8) weeks and 9–15 (average 12.7) months. We compared animals kept under standard
housing conditions (SH) vs. animals exposed to the EE from birth [9], including ad libitum access to
the running wheel, or kept on mild CR diet (food intake individually regulated to maintain the body
weight loss of 10–15%) for 4 to 6 weeks.
2.1. Slice and Cell Preparation
Mice were anaesthetized by halothane and then decapitated, in accordance with UK legislation.
Brains were removed rapidly after decapitation and placed into ice-cold physiological saline containing
(mM): NaCl 130, KCl 3, CaCl2 0.5, MgCl2 2.5, NaH2PO4 1, NaHCO3 25, glucose 15, pH of 7.4 gassed
with 95% O2–5% CO2. Transverse slices (260 µm) were cut at 4 ◦C and then placed in physiological
saline containing (mM): NaCl 130, KCl 3, CaCl2 2.5, MgCl2 1, NaH2PO4 1, NaHCO3 22, glucose 15,
pH of 7.4 gassed with 95% O2–5% CO2 and kept for 1.5 to 5 h prior to cell isolation and recording.
Astrocytes were identified by their morphology under differential contrast observation,
green fluorescent protein (GFP) fluorescence (astrocytes from dn-SNARE mice) or staining with
sulforhodamine 101 (astrocytes from WT and MSK1 KD mice). After recording, the identification
of astrocytes was confirmed via their functional properties (high potassium conductance, low input
resistance, and strong activity of glutamate transporters) as described previously [20–23]. To facilitate
high-quality whole-cell recordings in the brain tissue slices of old mice, tissue slices were treated with
a vibrating glass ball to remove the upper layer of dead cells and expose healthy neurons [24].
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Hippocampal cultures were prepared from WT and MKS1 KD mice as described previously [9].
Briefly, hippocampi were dissected, recovered by enzymatic digestion with trypsin and dissociated
through a Gilson pipette. For immunocytochemistry and for miniature excitatory postsynaptic currents
(mEPSC) recordings, cells were plated at a density of approximately 100,000 per dish onto 22-mm
glass coverslips coated with poly-L-lysine. Cultures were maintained at 37 ◦C in neurobasal medium
(Gibco, Themo Fisher Scientific, UK) containing 1% L-glutamine (Gibco), 1% penicillin–streptomycin
(Gibco) and 2% B27 supplement (Gibco) in a 95% O2/5% CO2-humidified incubator. Neurons were
used between 12 to 16 days in vitro.
2.2. Electrophysiological Recordings
Whole-cell voltage-clamp recordings from cortical neurones and astrocytes were made with
patch pipettes (4–5 MΩ) filled with intracellular solution (in mM): 110 CsCl, 10 NaCl, 10 HEPES,
5 MgATP, 1 D-Serine, 0.1 EGTA, pH 7.35. Currents were monitored using an MultiClamp 700B
patch-clamp amplifier (Axon Instruments, Union City, CA, USA) filtered at 2 kHz and digitized
at 4 kHz. Experiments were controlled by a Digidata1440A data acquisition board (Axon Instruments)
and WinWCP software (Strathclyde University, Edinburgh, UK); data were analysed by custom lab
software. Liquid junction potentials were compensated with the patch-clamp amplifier. The series and
input resistances were 5–7 MΩ and 700–1200 MΩ, respectively; both series and input resistance varied
by less than 20% in the cells accepted for analysis.
2.3. High-Resolution Scanning of Synaptic Boutons
Synaptic morphology was imaged in the neuronal cultures using the super-resolution hopping
probe ion conductance microscopy, an advanced version of scanning ion conductance microscopy
(SICM) [25]. The identification of synaptic boutons and SICM 3D topographical imaging were
carried out using a custom-modified SICM scanner ICNano (Ionoscope, London, UK), as described
previously [25]. Briefly, the sample was positioned in the X-Y directions with a nanopositioning stage
(Physik Instrumente, Karlsruhe, Germany) and the scanning pipette was positioned in Z-direction
with a piezoelectric actuator (PI). The fine-tipped scanning nanopipettes were pulled from borosilicate
glass (outer/internal diameter 1/0.5 mm) with a horizontal laser puller P-2000 (Sutter Instruments,
Novato, CA); pipette resistance was in the range of 80 to 100 MΩ corresponding to the estimated
tip diameter of 90–120 nm. Nanopipettes were held in voltage-clamp mode with an Axopatch 200B
patch-clamp amplifier (Axon Instruments); the amplifier head-stage was mounted on the z-scanning
head. The amplifier output signal was monitored by the SICM electronics, which simultaneously
controlled sample and pipette positioning.
The scan system was mounted onto an inverted microscope Nikon TE2000-U (Nikon Instruments,
Kingston, UK) equipped with epifluorescence illumination. The sample was preloaded with the
fluorescent synaptic marker FM1-43 (3 µM, 15 min loading followed by 15 min washout). FM1-43
fluorescence was imaged 100X 1.3 numerical aperture (NA) oil immersion objective and an EM-CCD
camera (Andor iXon3, Andor Technology, Belfast, UK). Synaptic boutons were identified by matching
the tentative boutons in topography and FM1-43 fluorescence [25]. The raw SICM data were
processed using Gwyddion 5.0 microscopy analysis software (Czech Metrology Institute, Brno, Czech
Republic) [26]. After constructing a 3D topographical image of identified synaptic varicosities,
their maximal span in X-Y-Z dimensions (∆x, ∆y and ∆z) was determined and the effective size
was calculated as the square root of (∆x2 + ∆y2 + ∆z2) quotient. The synaptic varicosity volume was
estimated as the volume of an ellipsoid of ∆x, ∆y and ∆z dimensions.
2.4. Multiphoton Fluorescent Ca2+-Imaging in Astrocytes
To monitor the cytoplasmic free Ca2+concentraton ([Ca2+]i) in situ, astrocytes of neocortical slices
were loaded via 30 min incubation with 1 µM of Rhod-2AM (dnSNARE mice) or Oregon Green
Bapta-2AM and sulphorhodamine 101 (wild-type and MSK1 KD mice) at 33 ◦C. Two-photon images
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of neurons and astrocytes were acquired at 5 Hz frame rate using a Zeiss LSM-7MP multiphoton
microscope (Carl Zeiss, Jena, Germany) coupled to a MaiTai (SpectraPhysics, Santa Clara CA, USA)
pulsing laser; experiments were controlled by ZEN LSM software (Carl Zeiss). Images were further
analysed offline using ZEN LSM (Carl Zeiss) and ImageJ 1.52 (NIH) software [27]. The [Ca2+]i levels
were expressed as ∆F/F ratio averaged over a region of interest (ROI). For analysis of spontaneous
Ca2+-transients in astrocytes, three ROIs located over dendrites and one ROI located over the soma
were chosen. Overall Ca2+-response to receptors agonists or synaptic stimulation was quantified using
an ROI covering the whole cell image.
2.5. Data Analysis
All data are presented as mean ± standard deviation (SD) and the statistical significance of
differences between data groups was tested by two-tailed unpaired t-test, unless indicated otherwise.
For all cases of statistical significance reported, the statistical power of the test was between 0.8 and 0.9.
The spontaneous transmembrane currents recorded in neurons were analysed offline using
methods described previously [20,21]. The amplitude distributions of spontaneous and evoked currents
were analysed with the aid of probability density functions and likelihood maximization techniques;
all histograms shown were calculated as probability density functions. The amplitude distributions
were fitted with either multiquantal binomial model or bimodal function consisting of two Gaussians
with variable peak location, width and amplitude. Parameters of models were fit using likelihood
maximization routine.
3. Results
3.1. Astroglia-Induced Homeostatic Synaptic Scaling in Cultured Neurons
A conventional approach to test molecular mechanisms of homeostatic synaptic plasticity is
exposure of primary neuronal cultures to conditions of chronic inhibition or enhancement of neuronal
firing, e.g., 24 h-long incubation with tetrodotoxin or picrotoxin [9,10]. To probe the specific role of
astrocytes, we modified this approach and selectively enhanced astroglial Ca2+-signalling with TFLLR,
an agonist of PAR-1 receptors [20]. The efficiency and specificity of PAR-1 receptor-mediated activation
of astrocytes and lack of such action in neurons have been verified previously [20].
The 24 h-long incubation with TFLLR (3 µM) caused a considerable increase in the amplitude
of mEPSCs in wild-type hippocampal pyramidal neurons (Figure 1A) suggesting that enhancement
of astrocytic signalling can induce synaptic scaling. The average mEPSC amplitude increased from
14.01 ± 2.77 pA (n = 11) to 26.7 ± 6.55 pA (n = 9, p < 0.01).
To confirm that the observed synaptic scaling was BDNF-dependent, we incubated wild-type
cultured neurones in TFLLR with Cyclotraxin-B (CTX-B, 10 nM), a selective and potent TrkB
receptor inhibitor which has been shown to block the actions of BDNF [28]. Addition of the TrkB
receptor inhibitor blocked the TFFLR-induced enhancement of mEPSCs (Figure 1A). Furthermore,
the glia-induced synaptic scaling was impaired in cell cultures derived from MSK1 KD mice
(Figure 1B,C) indicating the crucial role for BDNF-MSK1 pathway in this phenomenon.
Analysis of amplitude distributions of mEPSCs (Figure 1B) showed that the increase in the average
amplitude occurred due to an increase in the unitary quantal size of synaptic response (manifested
as the main peak of the amplitude distribution). The incubation with TFLLR alone caused a robust
increase in the quantal size of mEPSCs recorded in wild type neurons, whereas there was no significant
change in mEPSC frequency (Figure 1B,C). These results imply that glia-induced BDNF-dependent
homeostatic synaptic scaling occurs mainly via postsynaptic mechanisms, similar to previous reports
on various forms of homeostatic synaptic plasticity.
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Figure 1. Mitogen- and stress-activated protein kinase 1 and brain-derived neurotrophic factor mediate
astroglia-induced synaptic scaling in hippocampal neurons. (A) Synaptic scaling was induced in
cultured hippocampal pyramidal neurons via incubation with the selective astroglia activator TFLLR
(PAR-1 receptor agonist). Upper and middle panels show representative mEPSCs from wild-type
neurons in control media (upper left) and after 24 h incubation with either 3 µM TFLLR alone (upper
right) or the TrkB inhibitor Cyclotraxin B (CTX B) alone (middle left) or TFLLR and Cyclotraxin
B together (middle right). Bottom panels show mEPSCs recorded in neurons of MSK1 KD mice.
The insets on the right show corresponding average mEPSC waveforms. Note that incubation with
TFLLR upregulated only mEPSCs recorded in the wild-type mice under control conditions. Synaptic
currents were recorded at a membrane potential of −80 mV in the presence of picrotoxin (100 µM),
TTX (1 µM), and PPADS (10 µM). (B) Corresponding amplitude distributions recorded in the same
neurons as in (A). Note that the unitary quantal size, indicated by the position of the main peak in
the amplitude distribution, undergoes a considerable increase, suggesting a postsynaptic effect of
exposure to TFLLR in the wild-type, but not MSK1 KD neurons or in the WT neurons in the presence of
BDNF TrkB receptor blocker. (C) Bar graphs show the quantal size and average frequency of mEPSCs
recorded as described above. Data show mean ± SD for 9–12 neurons from three to four primary
neuronal cultures. Note the significant increase (p < 0.005, unpaired t-test) in the quantal mEPSC
amplitude in wild-type neurones after incubation with TFLLR. The lack of significant changes in the
mEPSC frequency supports the postsynaptic origin of the effect. In contrast, activation of astrocytes
with TFLLR did not cause significant alterations in mEPSCs in MSK KD1 neurons or WT neurons in
the presence of BDNF TrkB receptor blocker. * p < 0.005.
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3.2. Astroglia-Induced Homeostatic Changes in Synaptic Morphology
An enhancement of strength of excitatory synapses at postsynaptic locus can occur via two
principle pathways: an increase in efficacy of neurotransmitter receptors (i.e., permeability and
open time of glutamate receptor-associated ion channels) or an increase in their surface expression.
These functional alterations are often accompanied by changes in synaptic morphology, in particular
an increase in the size of dendritic spines. Brain-derived neurotrophic factor has been previously
implicated in the regulation of synaptic morphology via induction of Arc/Arg3.1 gene [9,29,30].
To elucidate whether this cascade is involved in the TFFLR-induced synaptic scaling, we assessed
the alterations in the size and shape of postsynaptic sites using SICM. This technique is based on
decrease in the ionic current passing through a glass microelectrode in close proximity of cells (or any
other obstacles). The SICM method enables the imaging of live cells at nanoscale resolution and
adequately maps the shape and size of small subcellular structures, such as dendrites, axons and
synaptic boutons [25]. This technique has been successfully used before in the structure–function
studies of synaptic networks of cultured hippocampal neurons and mechano-sensory stereocilia of
cochlear hair cells [25,31].
To test for the effects of astroglia-derived BDNF on synaptic morphology, we examined live
neurons from wild-type mice hippocampal cultures incubated with TFLLR alone, TFLLR with the
inhibitor of TrkB receptors, or BDNF (Figure 2A). To identify functional synapses, neurons were
labelled with FM1-43, an activity-dependent marker of synaptic vesicles, prior to SICM imaging
(Figure 2A). Whenever a FM1-43 signal was observed, varicosities could be mapped at the SICM
images; with the size and shape of varicosities consistent with the geometry expected of synaptic
boutons. We targeted fluorescently-labelled varicosities located on distal dendrites to increase the
probability of encountering excitatory synapses. Upon 3D-mapping of identified synaptic boutons
(Figure 2B), their volume and effective size were evaluated as described in Methods (Figure 2C).
Consistent with our observations of astroglia-induced increase in synaptic strength, 24 h-incubation
with TFLLR caused significant, up to 60%, increase in the average size of synapses (from 0.798 ±
0.223 µm to 1.248 ± 0.345 µm, p < 0.01). Correspondingly, the average volume of synaptic boutons
showed >2.5-fold increase, from 0.218 ± 0.208 µm3 to 0.569 ± 0.489 µm3 (n = 31, p < 0.01).
The effect of TFLLR was effectively antagonized by Cyclotraxin-B (average size increased by just
10%) and reproduced by incubation with BDNF (Figure 3C).
Combined with data on the changes in mEPSC amplitude (Figure 1), these results demonstrate
that activation of astrocytes can engage the BDNF-dependent molecular cascade, which is instrumental
for homeostatic regulation of synaptic strength.
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Figure 2. Astroglia and brain-derived neurotrophic factor (BDNF) regulate synaptic size. (A) The
principle of tomographic imaging of synaptic boutons using high-resolution hopping probe scanning
ion conductance microscopy (SICM). Synapses of live hippocampal neurons were prestained with
synaptic vesicle marker FM1-43. (B) High-resolution SICM 3D images of hippocampal synapses of
wild-type neurons in control and after 24 h incubation with 3 µM TFLLR. The X- and Y-scales are
indicated on the images, the Z-scale is indicated as pseudo-colour (same scale for both graphs). (C) The
pooled data on the volume (V; µm3 ) and size (∆L, µm) of synaptic boutons of wild-type neurons in
control and after 24 h-incubation with the PAR1 agonist TFLLR alone, TFLLR and the TrkB antagonist
Cyclotraxin B (CTX B), and BDNF. Open symbols indicate individual boutons, the closed symbols show
mean ± standard deviation for the whole group (n = 30–35 boutons for three preparations). Note the
significant increase in the size and volume of synapses after incubation with either TFLLR or BDNF.
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Figure 3. Age- and experience-dependent changes in astrocytic Ca2+ signalling. Astroglial Ca2+-signalling
was evaluated in the neocortex of 6–12 week-old (young) and 9–15 month-old mice (old) as described
previously [26–28]. The MSK1 KD and their wild-type littermates were kept either in standard housing
(SH) or exposed to environmental enrichment (EE) or caloric restriction (CR) as described in the
Methods. (A) Representative multiphoton images of astrocytes of old MSK1 KD mouse preloaded
with Oregon Green BAPTA-2 AM (OGB-2) and stained with fluorescent astroglial marker SR101 and
pseudo-colour images of OGB-2 fluorescence recorded before and after application of noradrenaline
(NA, 1 µM). Graphs below show the time course of OGB-2 fluorescence averaged over regions
indicated in the fluorescent images. Note the increase in the amplitude and frequency of spontaneous
Ca2+-elevations and in response to NA. (B) The pooled data on peak amplitude and frequency of the
baseline spontaneous Ca2+-transients recorded in astrocytes of WT, MSK1, and dn-SNARE mice of
different ages and treatments. Number and size of spontaneous events were pooled for the whole
cell image. (C) The pooled data on the net responses to application of 1 µM noradrenaline and 10 µM
ATP. Net response was evaluated as an integral Ca2+-signal measured within 3 min after stimulation,
averaged over the whole cell image and normalized to the baseline integral Ca2+ signal. Data in
the panels (B, C) are shown as mean ± SD for the 6 to 12 astrocytes from 3 to 4 animals. Asterisks
(*, **) correspondingly indicate statistical significance (p < 0.05) of the effect of EE or CR treatment
(as compared to SH) and difference between the old and young mice of the same treatment group
and genotype. Note the significant increase in spontaneous and evoked Ca2+-signalling in astrocytes
of mice exposed to EE and CR, and the lack of difference in Ca2+-signalling in the WT, MSK1 KD,
and dnSNARE mice.
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3.3. Astrocytes Participate in Homeostatic Plasticity In Vivo
BDNF-mediated homeostatic synaptic scaling has been implicated in the positive effects of
environmental enrichment on synaptic transmission [9]. There is also evidence that an increase in
BDNF can underlie the beneficial effects of a low-calorie diet on brain function [12,32]. Previously,
we demonstrated that environmental enrichment and caloric restriction can enhance Ca2+-signalling
in neocortical astrocytes [19]. Hence, one might predict that an increase in astroglial Ca2+-dependent
BDNF release plays a key role in the beneficial effects of EE and CR on synaptic transmission
in the aging brain. To explore the role of this signalling mechanism in a behavioural model of
experience-dependent synaptic plasticity, we examined the effect of environmental enrichment and
caloric restriction on excitatory and inhibitory synaptic transmission in the neocortex.
First, we verified that EE and CR can enhance Ca2+-signalling in neocortical astrocytes of MSK1
KD mice. Astroglial Ca2+-signalling was monitored using multiphoton fluorescence microscopy as
described previously [20,22,23]. We measured spontaneous cytosolic Ca2+ transients in the branches
and soma of neocortical astrocytes of 6–12 week-old (young adults) and 9–15 months old (old) mice
(Figure 3). There was no significant difference in Ca2+-signalling between neocortical astrocytes of old
wild-type and MSK1 KD mice (Figure 3). Similar to our previous reports, the amplitude and frequency
of spontaneous astrocytic Ca2+-transients in old WT and MSK1 KD mice raised in standard housing
(SH) were significantly lower than those measured in the young SH WT mice. Most importantly,
EE and CR significantly increased spontaneous astroglial Ca2+-signalling in the old WT and MSK1 KD
mice to a similar extent (Figure 3A,B).
We also assessed the responses of astrocytes to exogenous activation of NA and ATP receptors
since these neurotransmitters are released during enhanced neuronal and physical activity [21,33,34]
and potentially can mediate a link between environmental enrichment and the function of astrocytes.
There is also growing evidence of the importance of α1AR and P2Y receptors for astrocytic
Ca2+-signalling and glia–neuron interactions [21,22,33,34]. EE and CR had a moderate effect on
the amplitudes of astrocytic responses to NA (3 µM) and ATP (30 µM) in the young mice, but caused a
significant enhancement of astroglial responses at the older age, both in the WT and MSK1 KD mice
(Figure 3C).
These results have verified that Ca2+-signalling in astrocytes, and especially the effects of EE
and CR, are not affected by MSK1 KD knock-in. We have previously demonstrated that astroglial
Ca2+-signalling is not altered in the dnSNARE mice either [19,20,23]. Hence, if any difference in the
impact of EE and CR on synaptic transmission in the dnSNARE and MSK1 KD mice were observed,
they should be attributed not to the deficit in astroglial Ca2+-elevation, but rather to the impairment
of downstream signalling cascades, namely astroglial exocytosis and BDNF-mediated regulation of
neuronal synaptic strength.
To test this, we recorded AMPA receptor-mediated mEPSCs in neocortical pyramidal neurons in
the presence of the GABAA receptor antagonist picrotoxin (100 µM), and the P2 Receptor antagonist
PPADS (10 µM). Exposure of wild-type mice to EE from birth to 6–12 weeks increased the average
amplitude of mEPSCs to 18.6 ± 6.04 pA (n = 12), as compared to 21.3 ± 5.97 (n = 13) in the SH
mice. The difference between the EE and SH mice was even larger for the older mice (Figure 4A,B),
which might be related to the age-related decline in the amplitude of excitatory synaptic currents.
In the older mice, the mEPSC amplitude increased from 10.86 ± 3.55 pA (SH, n = 10) to 14.34 ± 3.47
pA (EE, n = 8).
Exposure to CR had similar positive effect on mEPSCs (Figure 4B). The observed effects of both EE
and CR were, most likely, of postsynaptic origin since they were accompanied by a significant increase
in quantal size, whereas the frequency of mEPSCs did not undergo considerable changes (Figure 4C).
In stark contrast to the WT mice, mEPSCs recorded from MSK1 KD mice undergo the same
age-related decline, but did not exhibit the EE- or CR-induced increase in amplitude (Figure 4A,B).
In line with data obtained in the MSK1 KD mice, the dnSNARE mice showed only modest EE- and
CR-induced increase in the average mEPSCs amplitude. The difference in the quantal size of mEPSCs
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in the WT and dnSNARE mice was statistically significant only for the EE in the younger age (p < 0.05).
The incomplete inhibition of EE-induced plasticity in the young dnSNARE mice could be attributed to
the mosaic (50–60% of cells) expression of dnSNARE and therefore incomplete loss of glial exocytosis.
In addition, neuronal release of BDNF cannot be excluded.
Figure 4. Experience-dependent alterations in excitatory synaptic transmission. AMPA receptor-mediated
spontaneous miniature excitatory postsynaptic currents (mEPSCs) were recorded in neocortical layer
2/3 pyramidal neurons at −80 mV in the presence of 100 µM picrotoxin, 1 µM TTX and 10 µM PPADS.
(A) Representative whole-cell currents recorded in young (top row) and old SH (middle row) and
EE (bottom row) WT, MSK1 KD and dnSNARE mice (left, middle, and right columns, respectively).
The inserts on the right shows average mEPSC waveforms. Note the significant decrease in mEPSC
amplitude in the old WT mice of standard housing, and upregulation of mEPSCs in the EE mice of
the same age. The effect of EE is impaired in the MSK1 KD and dnSNARE mice. (B, C) Pooled data
on the quantal size (B) and frequency (C) of mEPSCs in mice of different age and experience groups.
Data are shown as mean ± SD for the number of neurons indicated in (B). The statistical significance
(2-population unpaired t-test) for the difference between young and old mice of same genotype and
experience is indicated by (#) symbols; asterisks (*) indicate statistical significance of the difference
between different genotype and experience groups as indicated.
The dependence of EE- and CR-induced upscaling of excitatory synaptic currents on the MSK1
signalling pathway and astrocytic exocytosis closely agrees with our results obtained in cell cultures
(Figures 1 and 2). Combined together, our in vitro and ex vivo data strongly support the crucial
importance of astroglial release of BDNF for homeostatic plasticity of excitatory synaptic transmission.
Finally, we explored the experience-dependent plasticity of inhibitory synaptic signalling.
We recorded GABA receptor-mediated miniature inhibitory synaptic currents (mIPSCs) at a membrane
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potential of −80 mV in the presence of glutamate and P2X receptor antagonists (DNQX and PPADS,
respectively). The pattern of age- and environment-related alterations in the GABAergic synaptic
currents was different to the changes exhibited by mEPSCs. Firstly, both the quantal size and frequency
of mIPSCs undergo dramatic increase in older WT and the MSK1 KD mice (Figure 5). In addition,
GABAergic currents were upregulated in the dnSNARE mice of both age groups as compared to
their WT-littermates (Figure 5A,B); this result is in line with our previous observations [19]. Secondly,
exposure of the wild-type mice to EE and CR efficiently downregulated inhibitory synaptic signalling,
especially in the neurons of older mice (Figure 5A,B). In contrast to mEPSCs, the EE- and CR-induced
downscaling of mIPSCs was absent in the dnSNARE but not in the MSK1 KD mice. This might
be explained by participation of other gliotransmitters, in particular ATP [19], in astroglial-driven
modulation of GABA receptors.
Figure 5. Experience-dependent alterations in inhibitory synaptic transmission. GABAA receptor-mediated
miniature inhibitory postsynaptic currents (mIPSCs) were recorded in neocortical layer 2/3 pyramidal
neurons at −80 mV in the presence of 30 µM DNQX, 1 µM TTX, and 10 µM PPADS. (A) Representative
whole-cell currents recorded in young (top row) and old SH (middle row) and EE (bottom row) WT,
MSK1 KD, and dnSNARE mice (left, middle, and right columns, respectively). The inserts on the right
shows average mIPSCs waveforms. (B, C) Pooled data on the quantal size (B) and frequency (C) of
mIPSCs in mice of different age and experience groups. Data are shown as mean ± SD for the number
of neurons indicated in (B). The statistical significance (2-population unpaired t-test) for the difference
between young and old mice of same genotype and experience is indicated by (#) symbols; asterisks (*)
indicate statistically significance of the difference between different genotype and experience groups as
indicated. Note the significant increase in mIPSC amplitude in the old standard housed WT mice and
down-regulation of mIPSCs in the EE mice of the same age. The effect of EE is impaired in the MSK1
KD and dnSNARE mice.
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Combined, our data strongly support the importance of astrocytic exocytosis and BDNF/MSK1-
mediated signalling for the beneficial effects of EE and CR on synaptic transmission in the ageing brain.
4. Discussion
Our experiments in cultured neurons demonstrated that long-term enhancement of astrocytic
Ca2+-signalling can lead to neuronal synaptic scaling that engages the same BDNF/MSK1 cascade
that has been shown to underlie homeostatic synaptic plasticity induced by alterations in neuronal
firing [9,10]. The astrocyte-induced alterations in synaptic strength (Figure 1) and morphology
(Figure 2) depend on the activity of BDNF TrkB receptors and MSK1. Combined with recently reported
data unequivocally showing the ability of astrocytes to release BDNF via exocytosis [14], our results
strongly suggest that astrocyte-derived BDNF can modulate homeostatic synaptic scaling.
Our ex vivo data also highlighted the importance of astroglial-derived BDNF and the
BDNF/MSK1 pathway for experience-dependent homeostatic synaptic plasticity. Firstly, we observed
that exposure of mice to EE and CR can induce an increase in glutamatergic (Figure 4), and a decrease
in GABAergic synaptic transmission (Figure 5). The impact of EE and CR was significantly reduced in
dnSNARE mice, indicating the critical importance of astrocytic exocytosis, which is very likely the
main pathway of BDNF release [14]. Secondly, the effects of EE and CR on synaptic transmission and
plasticity differed significantly in the wild-type and MSK1 KD mice (Figures 4 and 5), where one of
the main pathways of BDNF-mediated homeostatic plasticity was impaired [9]. Finally, the exposure
to EE and CR led to significant upregulation of Ca2+-signalling in astrocytes, which did not differ
in the WT and transgenic mice. The most likely explanation for all our observations of changes in
glutamatergic mEPSCs would be the enhancement of Ca2+-dependent release of BDNF from astrocytes
which, in turn, upregulates the strength of excitatory synapses via MSK1-dependent cascade.
As for the homeostatic plasticity of GABAergic transmission, it was only weakly affected by
the impairment of the BDNF/MSK1 pathway, but was critically dependent on astroglial exocytosis.
These results highlight an important difference in astroglial-driven homeostatic regulation of excitatory
and inhibitory synaptic transmission: the former is modulated mainly via the BDNF/MSK1 pathway
whereas the latter is modulated, most likely, by other gliotransmitters. As our previous results suggest,
the vesicular release of ATP can play an important role in astroglial-driven modulation of GABA
receptors [20].
Our data highlighted interesting trends in age-related alterations in synaptic transmission:
a decrease in the efficacy of excitatory synapses, and an increase in the efficacy of inhibitory
synapses, but neither were accompanied by marked change in the frequency of synaptic events.
These observations suggest that, at least at early stages of ageing, neurons retain a significant number of
functional synapses, and cognitive decline can be associated with dysregulation, rather than complete
loss of synapses. Furthermore, our present (Figure 3) and previous data [19,35,36] on age-related
decline in astroglial Ca2+-signalling and the release of gliotransmitters suggest a very plausible reason
of such dysregulation—impairment of glia-driven modulation of synaptic activity. This hypothesis
is strongly supported by observation that manipulations which facilitate astroglial signalling, e.g.,
EE, CR, reversed the changes in excitatory and inhibitory synaptic signalling back to a “younger”
state (Figures 4 and 5). Also, the notion of impairment of glial regulation of balance between the
excitatory and inhibitory signals onto principal neurons as a putative cause of age-related cognitive
decline agrees with our previous observation that enhancement of astrocytic Ca2+-signalling, including
EE- and CR-induced, can rescue long-term synaptic plasticity in old mice [19,35,36]. Nonetheless,
this model of age-related alterations of synaptic function needs to be explored further, in particular in
relation to neurodegenerative disorders.
To conclude, our results strongly support the physiological importance of astroglial exocytosis,
in particular the release of BDNF, for communication between astrocytes and neurons and
experience-related synaptic plasticity across a lifetime.
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